论文部分内容阅读
目的：探讨前列腺炎样症状和慢性前列腺炎在不同类型早泄患者中的发生率及其相关性。方法对2013年2月至2013年12月于安徽医科大学第一附属医院男科门诊就诊的368名原发性和继发性早泄患者及我院体检中心316位健康无早泄体检者进行问卷调查及相关检查，调查表包括一般情况及美国国立卫生研究院CP症状评分指数表（NIH-CPSI）等内容。结果早泄组前列腺炎样症状及慢性前列腺炎发生率分别为33.1%和22.3%，均显著高于无早泄组（分别为14.2%，7.0%），差异具统计学意义（P＜0.001）；其中继发性早泄组前列腺炎样症状发生率为40.4%，显著高于原发性早泄组27.8%（P＜0.05）。NIH-CPSI评分早泄组总分11.2±7.9显著高于无早泄组6.2±5.0，其中，继发性早泄组NIH-CPSI评分也显著高于原发性早泄组。结论早泄患者前列腺炎样症状及慢性前列腺炎的发生率均高于无早泄组，其NIH-CPSI评分也较高。继发性早泄患者前列腺炎样症状发生率高于原发性早泄患者。“,”Objective To investigate the incidence of prostatitis-like symptoms(PLS) and chronic prostatitis(CP) in patients with different types of premature ejaculation(PE) and explore their relationship. Methods Between February 2013 and December 2013, 368 consecutive heterosexual men complaining of PE and 316 male healthy subjects without the complaint were enrolled in this study. Each of them completed a detailed face-to-face questionnaire on information of demographics, National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI), and received some tests. Results The prevelences of PLS and CP in the PE group(33.1%and 22.3%) were significantly higher than that inthe control group (14.2%, 7.0%, both P<0.001). And the prevalence of PLS in patients with acquired PE (40.4%) was higher than that in patients with lifelong PE(27.8%, P<0.05). The NIH-CPSI score was 11.2±7.9 in the PE group, showing significant difference compared with that of control subjects (6.2±5.0, P<0.001). And the score of the acquired PE group was higher than that of lifelong PE group. Conclusion The patients with PE had higher incidence of PLS and CP, and had higher NIH-CPSI scores than that of the control subjects. Incidence of PLS in the acquired PE group was higher than that of lifelong PE group.